<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>2025 FDA Approvals | Statmint</title>
  <meta name="description" content="Statmint provides a clean, trusted summary of the latest 2025 FDA drug approvals, tailored for healthcare investors and professionals.">
  <link rel="icon" href="statmint_logo.jpeg" type="image/jpeg" />
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet"/>
  <link href="https://unpkg.com/aos@2.3.4/dist/aos.css" rel="stylesheet"/>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&display=swap" rel="stylesheet"/>
  <style>
    :root {
      --primary: #0d6efd;
      --dark: #0a0a0a;
      --accent: #377dff;
      --muted: #6c757d;
    }

    body {
      font-family: 'Inter', sans-serif;
      background: #f8f9fa;
      color: #212529;
      margin: 0;
    }

    header {
      background: var(--dark);
      padding: 0.5rem 2rem;
      display: flex;
      justify-content: space-between;
      align-items: center;
      position: sticky;
      top: 0;
      z-index: 1000;
    }

    header img {
      height: 160px;
    }

    nav a {
      margin-left: 1.5rem;
      color: #fff;
      text-decoration: none;
      font-weight: 500;
    }

    nav a:hover {
      color: var(--accent);
    }

    .hero {
      background: linear-gradient(rgba(0,0,0,0.6), rgba(0,0,0,0.6)),
        url('fda-hero.jpg') center/cover no-repeat;
      color: #fff;
      text-align: center;
      padding: 7rem 2rem;
    }

    .hero h1 {
      font-size: 3rem;
      font-weight: 700;
      margin-bottom: 1rem;
    }

    .hero p {
      max-width: 800px;
      margin: 0 auto;
      font-size: 1.2rem;
      color: #dee2e6;
    }

    .section {
      padding: 4rem 2rem;
    }

    .section p.lead {
      max-width: 800px;
      margin: 0 auto 2rem;
      color: var(--muted);
    }

    table {
      background: #fff;
      border-collapse: collapse;
      width: 100%;
      border-radius: 8px;
      overflow: hidden;
    }

    th, td {
      padding: 1rem 1.2rem;
      border-bottom: 1px solid #dee2e6;
      text-align: left;
      vertical-align: top;
    }

    th {
      background: #f1f3f5;
      font-weight: 600;
      text-transform: uppercase;
      font-size: 0.9rem;
      letter-spacing: 0.05em;
    }

    tbody tr:hover {
      background: #f8f9fa;
    }

    footer {
      background: var(--dark);
      color: #adb5bd;
      text-align: center;
      padding: 2rem 1rem;
      font-size: 0.9rem;
    }

    footer a {
      color: var(--accent);
    }
  </style>
</head>
<body>

  <!-- ✅ Professional Header -->
  <header>
    <a href="index.html"><img src="statmint_logo.jpeg" alt="Statmint Logo"></a>
    <nav>
      <a href="index.html">Home</a>
      <a href="stocks.html">Healthcare Stocks</a>
      <a href="fda.html">FDA Approvals</a>
      <a href="ipos.html">Initial Public Offerings</a>
    </nav>
  </header>

  <!-- ✅ Hero Section -->
  <section class="hero" data-aos="fade-zoom-in">
    <h1 data-aos="fade-down" data-aos-delay="100">2025 FDA Drug Approvals</h1>
    <p data-aos="fade-up" data-aos-delay="200">
      A curated summary of the latest approved treatments, with context for investors and healthcare professionals.
    </p>
  </section>

  <!-- ✅ FDA Approvals Table -->
  <section class="section">
    <div class="container">
      <p class="lead text-center" data-aos="fade-up">
        Updated regularly — this table reflects the newest FDA approvals for 2025, covering impactful new therapies in rare diseases, oncology, and next-generation gene editing.
      </p>

      <div class="table-responsive" data-aos="fade-up" data-aos-delay="100">
        <table class="table">
          <thead>
            <tr>
              <th>Drug</th>
              <th>Company</th>
              <th>Indication</th>
              <th>Approval Date</th>
              <th>Summary</th>
              <th>Link</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>CTX001</td>
              <td>CRISPR Therapeutics & Vertex</td>
              <td>Sickle Cell Disease & Beta Thalassemia</td>
              <td>January 10, 2025</td>
              <td>First CRISPR gene-editing therapy approved for inherited blood disorders.</td>
              <td><a href="https://www.fda.gov/drugs" target="_blank">FDA</a></td>
            </tr>
            <tr>
              <td>VX-548</td>
              <td>Vertex Pharmaceuticals</td>
              <td>Acute & Neuropathic Pain</td>
              <td>February 22, 2025</td>
              <td>Non-opioid pain treatment approved for post-surgical and chronic nerve pain.</td>
              <td><a href="https://www.fda.gov/drugs" target="_blank">FDA</a></td>
            </tr>
            <tr>
              <td>SRP-9001</td>
              <td>Sarepta Therapeutics</td>
              <td>Duchenne Muscular Dystrophy</td>
              <td>April 5, 2025</td>
              <td>Gene therapy for DMD with confirmed efficacy and durability data.</td>
              <td><a href="https://www.fda.gov/drugs" target="_blank">FDA</a></td>
            </tr>
            <tr>
              <td>BEAM-101</td>
              <td>Beam Therapeutics</td>
              <td>Sickle Cell Disease</td>
              <td>June 18, 2025</td>
              <td>Base editing therapy offering next-gen correction for sickle cell.</td>
              <td><a href="https://www.fda.gov/drugs" target="_blank">FDA</a></td>
            </tr>
            <tr>
              <td>IMC-F106C</td>
              <td>Immunocore Holdings</td>
              <td>Advanced Melanoma</td>
              <td>August 2, 2025</td>
              <td>Novel TCR bispecific for patients failing checkpoint inhibitors.</td>
              <td><a href="https://www.fda.gov/drugs" target="_blank">FDA</a></td>
            </tr>
            <!-- Add more if needed -->
          </tbody>
        </table>
      </div>
    </div>
  </section>

  <!-- ✅ Footer -->
  <footer>
    <div class="container">
      <p>© 2025 Statmint. Approval data provided for informational purposes only. Refer to official FDA sources for updates.</p>
      <p>Questions? <a href="mailto:info@statmint.org">Contact us</a></p>
    </div>
  </footer>

  <script src="https://unpkg.com/aos@2.3.4/dist/aos.js"></script>
  <script>
    AOS.init({
      duration: 1000,
      once: true,
      easing: 'ease-in-out'
    });
  </script>
</body>
</html>
